{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:44:50Z","timestamp":1776084290191,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04228-3","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:34:57Z","timestamp":1772714097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of miR-26b-5p in prostate cancer and its regulatory effect on tumor progression"],"prefix":"10.1186","volume":"24","author":[{"given":"Chao","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiliang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"4228_CR1","doi-asserted-by":"crossref","unstructured":"Currie C, Bjerknes C, Myklebust T, Framroze B. Assessing the potential of small peptides for altering expression levels of the iron-regulatory genes FTH1 and TFRC and enhancing androgen receptor inhibitor activity in in vitro prostate cancer models. Int J Mol Sci. 2023;24(20):1\u201319.","DOI":"10.3390\/ijms242015231"},{"issue":"6","key":"4228_CR2","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.3892\/mmr.2016.5859","volume":"14","author":"S Xu","year":"2016","unstructured":"Xu S, Yi XM, Zhang ZY, Ge JP, Zhou WQ. miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma. Mol Med Rep. 2016;14(6):5025\u201332.","journal-title":"Mol Med Rep"},{"key":"4228_CR3","doi-asserted-by":"crossref","unstructured":"Zulian V, Fiscon G, Paci P, Garbuglia AR. Hepatitis B virus and micrornas: a bioinformatics approach. Int J Mol Sci. 2023;24(24):1\u201328.","DOI":"10.3390\/ijms242417224"},{"issue":"1","key":"4228_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-021-00288-3","volume":"26","author":"S Ma","year":"2021","unstructured":"Ma S, Wei H, Wang C, Han J, Chen X, Li Y. MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer. Cell Mol Biol Lett. 2021;26(1):52.","journal-title":"Cell Mol Biol Lett"},{"key":"4228_CR5","doi-asserted-by":"publisher","first-page":"101591","DOI":"10.1016\/j.tice.2021.101591","volume":"72","author":"P Hu","year":"2021","unstructured":"Hu P, Dong ZS, Zheng S, Guan X, Zhang L, Li L, et al. The effects of miR-26b-5p on fibroblast-like synovial cells in rheumatoid arthritis (RA-FLS) via targeting EZH2. Tissue Cell. 2021;72:101591.","journal-title":"Tissue Cell"},{"key":"4228_CR6","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.2147\/OTT.S119027","volume":"9","author":"G Cochetti","year":"2016","unstructured":"Cochetti G, Poli G, Guelfi G, Boni A, Egidi MG, Mearini E. Different levels of serum MicroRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role. Onco Targets Ther. 2016;9:7545\u201353.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"4228_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbac001","volume":"5","author":"Y Lin","year":"2022","unstructured":"Lin Y, Qi X, Chen J, Shen B. Multivariate competing endogenous RNA network characterization for cancer microRNA biomarker discovery: a novel bioinformatics model with application to prostate cancer metastasis. Precis Clin Med. 2022;5(1):pbac001.","journal-title":"Precis Clin Med"},{"issue":"1","key":"4228_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13046-021-01875-0","volume":"40","author":"S Giglio","year":"2021","unstructured":"Giglio S, De Nunzio C, Cirombella R, Stoppacciaro A, Faruq O, Volinia S, et al. A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients. J Experimental Clin Cancer Research: CR. 2021;40(1):79.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"11","key":"4228_CR9","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1681\/ASN.2014050477","volume":"26","author":"A Bertram","year":"2015","unstructured":"Bertram A, Lovric S, Engel A, Beese M, Wyss K, Hertel B, et al. Circulating ADAM17 level reflects disease activity in Proteinase-3 ANCA-Associated vasculitis. J Am Soc Nephrology: JASN. 2015;26(11):2860\u201370.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"4228_CR10","doi-asserted-by":"crossref","unstructured":"Mishra HK, Ma J, Mendez D, Hullsiek R, Pore N, Walcheck B. Blocking ADAM17 function with a monoclonal antibody improves sepsis survival in a murine model of polymicrobial sepsis. Int J Mol Sci. 2020;21(18):1\u201310.","DOI":"10.3390\/ijms21186688"},{"issue":"1","key":"4228_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/febs.16923","volume":"291","author":"MI Saad","year":"2024","unstructured":"Saad MI, Jenkins BJ. The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond. FEBS J. 2024;291(1):10\u201324.","journal-title":"FEBS J"},{"key":"4228_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1067134","volume":"2018","author":"M Stolarczyk","year":"2018","unstructured":"Stolarczyk M, Scholte BJ. The EGFR-ADAM17 axis in chronic obstructive pulmonary disease and cystic fibrosis lung pathology. Mediators Inflamm. 2018;2018:1067134.","journal-title":"Mediators Inflamm"},{"key":"4228_CR13","doi-asserted-by":"crossref","unstructured":"Sisto M, Ribatti D, Lisi S. ADAM 17 and Epithelial-to-Mesenchymal transition: the evolving story and its link to fibrosis and cancer. J Clin Med. 2021;10(15):1\u201316.","DOI":"10.3390\/jcm10153373"},{"issue":"8","key":"4228_CR14","first-page":"687","volume":"18","author":"F Lin","year":"2012","unstructured":"Lin F, Lin P, Liu X, Li D, Liu ZJ, Zou HF, et al. [Inhibitory effect of SiRNA targeting ADAM17 on the proliferation of prostate cancer PC-3 cells]. Zhonghua Nan Ke xue\u2009=\u2009National. J Androl. 2012;18(8):687\u201391.","journal-title":"J Androl"},{"issue":"2","key":"4228_CR15","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3892\/ol.2015.4014","volume":"11","author":"G Al-Kafaji","year":"2016","unstructured":"Al-Kafaji G, Al-Naieb ZT, Bakhiet M. Increased oncogenic microRNA-18a expression in the peripheral blood of patients with prostate cancer: a potential novel non-invasive biomarker. Oncol Lett. 2016;11(2):1201\u20136.","journal-title":"Oncol Lett"},{"issue":"1","key":"4228_CR16","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1038\/s41467-024-46370-0","volume":"15","author":"H Cai","year":"2024","unstructured":"Cai H, Zhang B, Ahrenfeldt J, Joseph JV, Riedel M, Gao Z, et al. CRISPR\/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam\/Cabs1 gene cluster expression. Nat Commun. 2024;15(1):2088.","journal-title":"Nat Commun"},{"issue":"5","key":"4228_CR17","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1007\/s10620-021-06975-7","volume":"67","author":"B Zhou","year":"2022","unstructured":"Zhou B, Zhang W, Yan Z, Zhao B, Zhao J, Feng W, et al. MicroRNA-26b-5p targets DAPK1 to reduce intestinal Ischemia\/Reperfusion injury via Inhibition of intestinal mucosal cell apoptosis. Dig Dis Sci. 2022;67(5):1794\u2013805.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"4228_CR18","first-page":"655","volume":"20","author":"Z Gu","year":"2024","unstructured":"Gu Z, Zhang S, Zhao S, Cui Y, Sun L. Emodin improves the cardiac function in the rats with chronic heart failure through regulation of the miR-26b-5p\/PTEN pathway. Arch Med Sci-AMS. 2024;20(2):655\u201363.","journal-title":"Arch Med Sci-AMS"},{"key":"4228_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cellsig.2018.11.011","volume":"59","author":"W Han","year":"2019","unstructured":"Han W, Li N, Liu J, Sun Y, Yang X, Wang Y. MicroRNA-26b-5p enhances T cell responses by targeting PIM-2 in hepatocellular carcinoma. Cell Signal. 2019;59:182\u201390.","journal-title":"Cell Signal"},{"issue":"9","key":"4228_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.prp.2018.07.025","volume":"214","author":"CM Jia","year":"2018","unstructured":"Jia CM, Tian YY, Quan LN, Jiang L, Liu AC. MiR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1. Pathol Res Pract. 2018;214(9):1388\u201394.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"4228_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02336-4","volume":"22","author":"Y Qian","year":"2024","unstructured":"Qian Y, Chu G, Zhang L, Wu Z, Wang Q, Guo JJ, et al. M2 macrophage-derived exosomal miR-26b-5p regulates macrophage polarization and chondrocyte hypertrophy by targeting TLR3 and COL10A1 to alleviate osteoarthritis. J Nanobiotechnology. 2024;22(1):72.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"4228_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01873-6","volume":"9","author":"L Sun","year":"2024","unstructured":"Sun L, Jiao A, Liu H, Ding R, Yuan N, Yang B, et al. Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8(+) T cell effector differentiation and anti-tumor immunity. Signal Transduct Target Ther. 2024;9(1):152.","journal-title":"Signal Transduct Target Ther"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04228-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04228-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04228-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:48:31Z","timestamp":1776080911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04228-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4228"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04228-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by The Ethics Committee of Xuzhou Medical University Affiliated Xuzhou Municipal Hospital and followed the principles outlined in the Declaration of Helsinki.All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}